CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
San Diego’s Top 50 Black Leaders Awards
Feb 27, 2023
One of San Diego’s Top 50 Black Leaders Aims to Change the Life Sciences Industry San Diego, Calif. – The San Diego Business Journal has recognized California Life Sciences’..
Read More Life Sciences Startup Accelerator Program to Help Record Number of Companies
Feb 22, 2023
February 22, 2023 SAN FRANCISCO, SAN DIEGO, LOS ANGELES, SACRAMENTO, Calif. – A dozen life sciences startups have been selected to receive 12 weeks of business mentoring from expert advisors..
Read More CLS applauds Congress for passage of the CAROL Act, supporting research for valvular heart disease
Dec 5, 2022
December 5, 2022 California Life Sciences (CLS) commends the Senate and the House of Representatives on the passage of the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, which..
Read More California Life Sciences announces formal collaboration with Life Science Nation
Nov 7, 2022
November 7, 2022 SAN FRANCICSO, Calif, — California Life Sciences (CLS), the state’s most impactful life sciences membership organization, announced today that it has entered into a collaboration with Life Science Nation..
Read More California Life Sciences announces 19th annual Pantheon Award Winners
Nov 4, 2022
November 4, 2022 SAN FRANCISCO, Calif. – California Life Sciences (CLS), the state’s most impactful life sciences trade association, today announced the winners of its 19th annual Pantheon Awards. The..
Read More Announcing the Awardees of the CLS Inspire QuickFire Challenge for BIPOC Communities
Nov 3, 2022
November 3, 2022 – California Life Sciences (CLS), together with Johnson & Johnson Innovation and AbbVie, announced today that HOPO Therapeutics, IHP Therapeutics, and LEVEL 42 AI, Inc. have been..
Read More